Dendreon Corp (DNDN) 0.13 $DNDN
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 12, 7:48AM CST
Companies like AbbVie (ABBV), Gilead (GILD) and Achillion (ACHN) had a strong presence at the annual Liver Meeting.
VRTX: 112.72 (-3.96), GILD: 104.20 (-2.70), ACHN: 13.49 (-1.36), DNDN: 0.13 (-0.03), AMGN: 160.85 (-1.08), ABBV: 63.63 (-0.13), REGN: 402.63 (+1.52)
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
PR Newswire - Wed Nov 12, 7:45AM CST
EarningForecast.com has issued six earnings forecast research reports with special focus on financial performance of the following stocks: Alibaba (NYSE:BABA), Apple (NASDAQ:AAPL), Zynga (NASDAQ:ZNGA), Gilead Sciences (NASDAQ:GILD), Dendreon (NASDAQ
NDN), and Juniper (NYSE:JNPR).
GILD: 104.20 (-2.70), DNDN: 0.13 (-0.03), ZNGA: 2.73 (-0.08), AAPL: 112.82 (+1.57), JNPR: 20.45 (-0.42), BABA: 114.84 (-3.36)
Nasdaq stocks posting largest volume increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
HEAR: 4.03 (+0.02), LSBK: 12.70 (-0.10), VSAR: 19.17 (-0.36), SANW: 3.63 (+0.18), URRE: 2.01 (-0.48), EDUC: 4.22 (+0.01), MCEP: 16.81 (+0.28), CYAN: 6.52 (+0.54), DNDN: 0.13 (-0.03), SUMR: 2.91 (+0.11), CRTN: 3.90 (-0.21)
Most active Nasdaq-traded stocks
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 74.25 (-0.47), ACHN: 13.49 (-1.36), DNDN: 0.13 (-0.03), CMCSK: 54.03 (+0.63), ARCP: 8.81 (+0.02), ZNGA: 2.73 (-0.08), MSFT: 49.61 (+0.83), INTC: 33.68 (+0.30), GRPN: 7.77 (-0.33), CMCSA: 54.30 (+0.70), AAPL: 112.82 (+1.57), CSCO: 25.68 (+0.57)
Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:45PM CST
Dendreon filed voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
MDVN: 107.21 (+0.88), AGN: 196.21 (-0.30), JNJ: 109.07 (+0.32), DNDN: 0.13 (-0.03)
Update: Dendreon Bankruptcy
Alexander Maxwell - at Seeking Alpha - Tue Nov 11, 12:55PM CST
DNDN: 0.13 (-0.03)
Clarification: Dendreon-Chapter 11 Filing story
By The Associated Press - AP - Tue Nov 11, 12:43PM CST
In a story Nov. 10, The Associated Press reported that Bank of New York Mellon was listed as the largest creditor in a Chapter 11 bankruptcy court filing involving the drugmaker Dendreon Corp. BNY Mellon administers $620 million in notes for investors; it does not own them.
DNDN: 0.13 (-0.03)
Bankruptcies, Breakouts, and Busts; What's Happening in Biotech?
ACCESSWIRE - Tue Nov 11, 10:34AM CST
CORAL GABLES, FL / ACCESSWIRE / November 11, 2014 / From prostate cancer drugs to stem-cell therapy, the biotech industry seems to encompass a variety of unique and innovative companies. According to market research firm IBISWorld, the global revenue of the Biotech industry is nearly $300 billion. Statista reports that more that $50Billion of US biopharmaceutical goods are exported and the industry is on pace to grow at a compounded annual rate of nearly 11%. IBIS notes that many small companies, alongside a few industry giants in pharmaceutical, chemical and agricultural firms, populate the global biotech industry. There is also a lower level of market share concentration as noted by IBISWorld estimates that the top four industry players will account for less than 28% of the industry's revenue in 2014. With so much potential there are certainly companies in the market, which have progressed to the next level and others that have mismanaged their businesses into bankruptcy.
DNDN: 0.13 (-0.03)
Are Expensive Biotech Drugs Bad For Business?
Keith Williams - at Seeking Alpha - Tue Nov 11, 9:45AM CST
VRTX: 112.72 (-3.96), GILD: 104.20 (-2.70), MRK: 59.54 (+0.23), DNDN: 0.13 (-0.03), AZN: 74.53 (+0.27), TEVA: 57.17 (-1.27), ABBV: 63.63 (-0.13), GSK: 45.66 (+0.04), BMY: 57.80 (-0.81), NVS: 94.38 (+1.72)
Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes
at The Street - Mon Nov 10, 2:02PM CST
Though the S&P 500 has rallied to record highs over the past three weeks, analysts predict markets will continue to climb through to year's end.
KSS: 56.07 (-1.84), GPRO: 76.47 (-0.38), DNDN: 0.13 (-0.03), MCD: 95.48 (+0.15), M: 61.57 (unch), TWC: 141.05 (+4.57), TOL: 33.73 (+0.22), CMCSA: 54.30 (+0.70), BABA: 114.84 (-3.36)
Will Puma Biotechnology (PBYI) Disappoint this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:40PM CST
Puma Biotechnology (PBYI) is expected to report third-quarter 2014 results before the opening bell on Nov 11.
MNK: 86.96 (-6.03), DNDN: 0.13 (-0.03), PFE: 30.42 (unch), PBYI: 239.49 (+3.37)
Stock Market Today: Wall Street Is Static With Little News to Move Markets
at The Street - Mon Nov 10, 9:44AM CST
U.S. stocks make little movement on Monday following a three-week rally.
KSS: 56.07 (-1.84), GPRO: 76.47 (-0.38), DNDN: 0.13 (-0.03), MCD: 95.48 (+0.15), M: 61.57 (unch), TWC: 141.05 (+4.57), TOL: 33.73 (+0.22), CMCSA: 54.30 (+0.70)
Dendreon Files For Bankruptcy
Bill Maurer - at Seeking Alpha - Mon Nov 10, 9:03AM CST
DNDN: 0.13 (-0.03)
Dendreon has debt holders on board
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:31AM CST
DNDN: 0.13 (-0.03)
Today's Market: Merger And Acquisition Activity, Tech News And Bankruptcies
Matthew Smith - at Seeking Alpha - Mon Nov 10, 8:13AM CST
T: 35.61 (+0.21), AMX: 23.22 (+0.37), COF: 81.60 (+0.03), DNDN: 0.13 (-0.03), DTV: 87.50 (+0.12), WFC: 53.39 (-0.15), VOD: 35.35 (+0.01), BK: 39.59 (-0.15)
Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics
PR Newswire - Mon Nov 10, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Dendreon Corporation (NASDAQ: DNDN), Alkermes PLC (NASDAQ: ALKS), Exact Sciences Corporation (NASDAQ: EXAS), Inovio Pharmaceuticals Inc. (NASDAQ: INO), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, November 07, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,573.93, up 0.11% and the NASDAQ Composite closed at 4,632.53, down 0.13%. The S&P 500 finished the session 0.03% higher at 2,031.92. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 775.27, down 0.94%, whereas the index has gained 10.75% in the previous three months. Register for your complimentary reports on these five stocks at:
INO: 11.01 (-0.09), SGEN: 36.89 (-0.91), DNDN: 0.13 (-0.03), EXAS: 23.11 (+0.61), ALKS: 53.22 (+0.22)
Dendreon misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:01AM CST
DNDN: 0.13 (-0.03)
Why Earnings Season Could Be Great for Dendreon (DNDN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:51AM CST
Dendreon has a favorable Zacks Rank and an ESP in positive territory, thus investors might want to consider this stock ahead of earnings.
DNDN: 0.13 (-0.03)
Stock Market Today: Futures Rise Slightly as Stocks Set Up for Further Records
at The Street - Mon Nov 10, 7:31AM CST
U.S. stock futures are slightly higher on Monday morning, setting up for even more record highs in what will likely be a quiet week on Wall Street.
WWAV: 36.14 (+0.10), RIG: 26.29 (-0.79), DNDN: 0.13 (-0.03), M: 61.57 (unch), BA: 128.53 (+2.66), TOL: 33.73 (+0.22), K: 63.80 (+0.12)
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 12, 7:48AM CST
Companies like AbbVie (ABBV), Gilead (GILD) and Achillion (ACHN) had a strong presence at the annual Liver Meeting.
VRTX: 112.72 (-3.96), GILD: 104.20 (-2.70), ACHN: 13.49 (-1.36), DNDN: 0.13 (-0.03), AMGN: 160.85 (-1.08), ABBV: 63.63 (-0.13), REGN: 402.63 (+1.52)
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
PR Newswire - Wed Nov 12, 7:45AM CST
EarningForecast.com has issued six earnings forecast research reports with special focus on financial performance of the following stocks: Alibaba (NYSE:BABA), Apple (NASDAQ:AAPL), Zynga (NASDAQ:ZNGA), Gilead Sciences (NASDAQ:GILD), Dendreon (NASDAQ
NDN), and Juniper (NYSE:JNPR). GILD: 104.20 (-2.70), DNDN: 0.13 (-0.03), ZNGA: 2.73 (-0.08), AAPL: 112.82 (+1.57), JNPR: 20.45 (-0.42), BABA: 114.84 (-3.36)
Nasdaq stocks posting largest volume increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
HEAR: 4.03 (+0.02), LSBK: 12.70 (-0.10), VSAR: 19.17 (-0.36), SANW: 3.63 (+0.18), URRE: 2.01 (-0.48), EDUC: 4.22 (+0.01), MCEP: 16.81 (+0.28), CYAN: 6.52 (+0.54), DNDN: 0.13 (-0.03), SUMR: 2.91 (+0.11), CRTN: 3.90 (-0.21)
Most active Nasdaq-traded stocks
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 74.25 (-0.47), ACHN: 13.49 (-1.36), DNDN: 0.13 (-0.03), CMCSK: 54.03 (+0.63), ARCP: 8.81 (+0.02), ZNGA: 2.73 (-0.08), MSFT: 49.61 (+0.83), INTC: 33.68 (+0.30), GRPN: 7.77 (-0.33), CMCSA: 54.30 (+0.70), AAPL: 112.82 (+1.57), CSCO: 25.68 (+0.57)
Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:45PM CST
Dendreon filed voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
MDVN: 107.21 (+0.88), AGN: 196.21 (-0.30), JNJ: 109.07 (+0.32), DNDN: 0.13 (-0.03)
Update: Dendreon Bankruptcy
Alexander Maxwell - at Seeking Alpha - Tue Nov 11, 12:55PM CST
DNDN: 0.13 (-0.03)
Clarification: Dendreon-Chapter 11 Filing story
By The Associated Press - AP - Tue Nov 11, 12:43PM CST
In a story Nov. 10, The Associated Press reported that Bank of New York Mellon was listed as the largest creditor in a Chapter 11 bankruptcy court filing involving the drugmaker Dendreon Corp. BNY Mellon administers $620 million in notes for investors; it does not own them.
DNDN: 0.13 (-0.03)
Bankruptcies, Breakouts, and Busts; What's Happening in Biotech?
ACCESSWIRE - Tue Nov 11, 10:34AM CST
CORAL GABLES, FL / ACCESSWIRE / November 11, 2014 / From prostate cancer drugs to stem-cell therapy, the biotech industry seems to encompass a variety of unique and innovative companies. According to market research firm IBISWorld, the global revenue of the Biotech industry is nearly $300 billion. Statista reports that more that $50Billion of US biopharmaceutical goods are exported and the industry is on pace to grow at a compounded annual rate of nearly 11%. IBIS notes that many small companies, alongside a few industry giants in pharmaceutical, chemical and agricultural firms, populate the global biotech industry. There is also a lower level of market share concentration as noted by IBISWorld estimates that the top four industry players will account for less than 28% of the industry's revenue in 2014. With so much potential there are certainly companies in the market, which have progressed to the next level and others that have mismanaged their businesses into bankruptcy.
DNDN: 0.13 (-0.03)
Are Expensive Biotech Drugs Bad For Business?
Keith Williams - at Seeking Alpha - Tue Nov 11, 9:45AM CST
VRTX: 112.72 (-3.96), GILD: 104.20 (-2.70), MRK: 59.54 (+0.23), DNDN: 0.13 (-0.03), AZN: 74.53 (+0.27), TEVA: 57.17 (-1.27), ABBV: 63.63 (-0.13), GSK: 45.66 (+0.04), BMY: 57.80 (-0.81), NVS: 94.38 (+1.72)
Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes
at The Street - Mon Nov 10, 2:02PM CST
Though the S&P 500 has rallied to record highs over the past three weeks, analysts predict markets will continue to climb through to year's end.
KSS: 56.07 (-1.84), GPRO: 76.47 (-0.38), DNDN: 0.13 (-0.03), MCD: 95.48 (+0.15), M: 61.57 (unch), TWC: 141.05 (+4.57), TOL: 33.73 (+0.22), CMCSA: 54.30 (+0.70), BABA: 114.84 (-3.36)
Will Puma Biotechnology (PBYI) Disappoint this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:40PM CST
Puma Biotechnology (PBYI) is expected to report third-quarter 2014 results before the opening bell on Nov 11.
MNK: 86.96 (-6.03), DNDN: 0.13 (-0.03), PFE: 30.42 (unch), PBYI: 239.49 (+3.37)
Stock Market Today: Wall Street Is Static With Little News to Move Markets
at The Street - Mon Nov 10, 9:44AM CST
U.S. stocks make little movement on Monday following a three-week rally.
KSS: 56.07 (-1.84), GPRO: 76.47 (-0.38), DNDN: 0.13 (-0.03), MCD: 95.48 (+0.15), M: 61.57 (unch), TWC: 141.05 (+4.57), TOL: 33.73 (+0.22), CMCSA: 54.30 (+0.70)
Dendreon Files For Bankruptcy
Bill Maurer - at Seeking Alpha - Mon Nov 10, 9:03AM CST
DNDN: 0.13 (-0.03)
Dendreon has debt holders on board
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:31AM CST
DNDN: 0.13 (-0.03)
Today's Market: Merger And Acquisition Activity, Tech News And Bankruptcies
Matthew Smith - at Seeking Alpha - Mon Nov 10, 8:13AM CST
T: 35.61 (+0.21), AMX: 23.22 (+0.37), COF: 81.60 (+0.03), DNDN: 0.13 (-0.03), DTV: 87.50 (+0.12), WFC: 53.39 (-0.15), VOD: 35.35 (+0.01), BK: 39.59 (-0.15)
Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics
PR Newswire - Mon Nov 10, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Dendreon Corporation (NASDAQ: DNDN), Alkermes PLC (NASDAQ: ALKS), Exact Sciences Corporation (NASDAQ: EXAS), Inovio Pharmaceuticals Inc. (NASDAQ: INO), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, November 07, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,573.93, up 0.11% and the NASDAQ Composite closed at 4,632.53, down 0.13%. The S&P 500 finished the session 0.03% higher at 2,031.92. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 775.27, down 0.94%, whereas the index has gained 10.75% in the previous three months. Register for your complimentary reports on these five stocks at:
INO: 11.01 (-0.09), SGEN: 36.89 (-0.91), DNDN: 0.13 (-0.03), EXAS: 23.11 (+0.61), ALKS: 53.22 (+0.22)
Dendreon misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:01AM CST
DNDN: 0.13 (-0.03)
Why Earnings Season Could Be Great for Dendreon (DNDN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:51AM CST
Dendreon has a favorable Zacks Rank and an ESP in positive territory, thus investors might want to consider this stock ahead of earnings.
DNDN: 0.13 (-0.03)
Stock Market Today: Futures Rise Slightly as Stocks Set Up for Further Records
at The Street - Mon Nov 10, 7:31AM CST
U.S. stock futures are slightly higher on Monday morning, setting up for even more record highs in what will likely be a quiet week on Wall Street.
WWAV: 36.14 (+0.10), RIG: 26.29 (-0.79), DNDN: 0.13 (-0.03), M: 61.57 (unch), BA: 128.53 (+2.66), TOL: 33.73 (+0.22), K: 63.80 (+0.12)
